Track&Field, Serena Energia, and Dasa: Q2 2025 Financial Results Tell Brazil’s Corporate Story
In the second quarter of 2025, Brazil’s Track&Field, Serena Energia, and Dasa—the faces of retail, energy, and healthcare
In the second quarter of 2025, Brazil’s Track&Field, Serena Energia, and Dasa—the faces of retail, energy, and healthcare—each illustrated unique challenges and progress within Latin America’s largest economy.
Track&Field outfits the country’s growing sports culture; Serena Energia drives ambitious growth in the power sector; and Dasa delivers diagnostics and medical services nationwide.
Their results this quarter reflect not just numbers, but the deep currents of risk, ambition, and market reality that shape Brazil’s evolving corporate landscape.
Track&Field: Retailer Running Fast to Stay Ahead
Track&Field, a leading athletic apparel retailer, reported a net profit of R$34 million (about $6 million), up 30% from last year. Sales leapt to R$242 million (about $44 million), a strong 26% increase as health and wellness remain top-of-mind for Brazilian consumers.
EBITDA (earnings before interest, taxes, depreciation, and amortization) hit R$58 million ($11 million), up 33%, with higher margins reflecting growing demand and effective brand management.
However, financial costs climbed with a net expense of R$7 million ($1 million)—a likely result of funding continued expansion. The company opened more stores, now operating 406 locations, a 9% annual increase, and boosted same-store sales by 22%.
Still, cash reserves dropped to R$24 million ($4 million) from R$50 million ($9 million) just three months ago, highlighting the heavy investment into new stores and inventory.
Track&Field’s growth story shows both the rewards and the rapid spending required to lead in Brazil’s dynamic retail landscape.
Serena Energia: Balancing Soaring Revenues and Heavy Debt
Serena Energia, a key player in electricity generation and trading, nearly doubled its revenues to R$1.46 billion ($265 million), up 92% from last year.
EBITDA also grew, reaching R$422 million ($77 million), driven by new contracts and a R$70 million ($13 million) boost from its energy platform.
Even with this revenue explosion, Serena closed the quarter with a net loss of R$36 million ($7 million), an improvement over last year’s loss of R$103 million ($19 million).
The main challenge is still high financial expenses—a negative result of R$276 million ($50 million)—due to the weight of R$8.6 billion ($1.6 billion) in net debt and a leverage ratio of 4.4 times EBITDA.
Operating costs held steady at R$53 million ($10 million), showing good internal discipline, and shrinking losses point to progress beneath the surface.
Serena’s high-growth, high-debt strategy is classic in fast-changing emerging markets: invest quickly and hope growing revenues—and margins—outpace mounting financial costs.
Dasa: Healthcare Leader Restructures Amid Deep Losses
Dasa, one of Brazil’s largest diagnostics and health services groups, posted a net loss of R$176 million ($32 million), up 74%, with total revenue plunging nearly 38% to R$2.7 billion ($491 million).
Much of this drop stems from spinning off its hospital business with Amil, transferring about R$3.5 billion ($636 million) in debt to the new company. This move sharply reduced Dasa’s leverage from 4.2 to 2.8 times EBITDA—a tough but critical shift.
Amid the restructuring, Dasa’s diagnostics segment proved resilient: revenues climbed 6% to R$2.1 billion ($382 million), and EBITDA grew 10% to R$738 million ($134 million).
The firm also generated a positive operating cash flow of R$44 million ($8 million), a key sign of stability as it navigates through turbulence.
Dasa’s struggle is about more than numbers—it’s about taking short-term pain to build a more focused, less indebted company ready for the future of healthcare.
This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error
LatAm Markets: Live Signals → — real-time movers, turnover leaders and FX across Latin America.